IP Library › Granted Patent US 8,882,654
Granted Patent B2
US 8,882,654 · App. 14/080,929 · Granted Nov 11, 2014

Method for treating fecal incontinence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,882,654
App. No.
14/080,929
Granted
Nov 11, 2014
Kind
B2
Abstract

A method for treating fecal incontinence in a body of a mammal having a rectum formed by a rectal wall extending to an anus wherein the rectal wall includes a sphincter muscle surrounding the anus. At least one nonaqueous solution is introduced into the rectal wall in the vicinity of the anus. A nonbiodegradable solid is formed in the rectal wall from the at least one nonaqueous solution.

Claims (11)

1. A method for treating fecal incontinence in a body having an anal sphincter comprising the step of forming at least one nonbiodegradable implant in said sphincter by introducing a biocompatible prepolymer into the wall and polymerizing the biocompatible prepolymer in situ to form a biocompatible polymer.

2. The method of claim 1 wherein said sphincter has a damaged portion, further including the step of bridging the damaged portion with the implant.

3. The method of claim 1 , wherein the biocompatible prepolymer comprises a contrast agent.

4. The method of claim 3 , wherein the biocompatible prepolymer is viewed upon injection by fluoroscopy.

5. The method of claim 1 , wherein the wall comprises a submucosal layer and wherein the biocompatible prepolymer is injected into the submucosal layer.

6. The method of claim 1 , wherein the biocompatible prepolymer is a cyanoacrylate prepolymer.

7. A method for treating a wall of a gastrointestinal tract of a mammal comprising forming at least one nonbiodegradable implant in the wall by introducing a biocompatible prepolymer into the wall and polymerizing the biocompatible prepolymer in situ to form a biocompatible polymer.

8. The method of claim 7 , wherein the biocompatible prepolymer comprises a contrast agent.

9. The method of claim 8 , wherein the biocompatible prepolymer is viewed upon injection by fluoroscopy.

10. The method of claim 7 , wherein the wall comprises a submucosal layer and wherein the biocompatible prepolymer is injected into the submucosal layer.

11. The method of claim 7 , wherein the biocompatible prepolymer is a cyanoacrylate prepolymer.